Results 161 to 170 of about 10,778,046 (183)

From Vasoactive Intestinal Peptide (VIP) Through Activity-Dependent Neuroprotective Protein (ADNP) to NAP: A View of Neuroprotection and Cell Division

Journal of Molecular Neuroscience, 2003
Accelerated neuronal death brings about cognitive as well as motor and other dysfunctions. A major neuropeptide, vasoactive intestinal peptide (VIP), has been shown to be neuroprotective. However, VIP-based drug design is hampered by the instability of the peptide and its limited bioavailability.
Illana, Gozes, Inna, Divinsky, Inbar, Pilzer, Mati, Fridkin, Douglas E, Brenneman, Avron D, Spier   +5 more
openaire   +2 more sources

Localization of activity-dependent neuroprotective protein (ADNP) in neurospheres

Molecular Psychiatry, 2023
Sarah A, Bennison, Sara M, Blazejewski, Xiaonan, Liu, Gal, Hacohen-Kleiman, Shlomo, Sragovich, Sofia, Zoidou, Olga, Touloumi, Nikolaos, Grigoriadis, Illana, Gozes, Kazuhito, Toyo-Oka   +9 more
openaire   +2 more sources

Vasoactive Intestinal Peptide (VIP) Regulates Activity-Dependent Neuroprotective Protein (ADNP) Expression In Vivo

Journal of Molecular Neuroscience, 2007
Vasoactive intestinal peptide (VIP) is an important mediator of development during the neural tube closure period of embryogenesis and may regulate, in part, the expression of activity-dependent neuroprotective protein (ADNP), which is essential for neural tube closure and embryogenesis.
Eliezer, Giladi, Joanna M, Hill, Efrat, Dresner, Conor M, Stack, Illana, Gozes   +4 more
openaire   +2 more sources

Sexual divergence in activity‐dependent neuroprotective protein impacting autism, schizophrenia, and Alzheimer's disease

Journal of Neuroscience Research, 2016
Discovered in our laboratory, activity‐dependent neuroprotective protein (ADNP) interacts with key regulatory proteins, including the chromatin remodeling complex SWI/SNF, proteins associated with RNA splicing, RNA translation, microtubule dynamics, and autophagy.
openaire   +2 more sources

A human homologue for activity-dependent neuroprotective protein

Neuroscience Letters, 1997
R. Zamostiano, M. Bassan, A. Davidson, D.E. Brenneman, I. Gozes   +4 more
openaire   +1 more source

A femtomolar-acting activity-dependent neuroprotective protein (ADNP)

Neuroscience Letters, 1997
I. Gozes, M. Bassan, R. Zamostiano, A. Davidson, O. Perl, H. Bassan, C. Blat, E. Giladi, G. Gibney, G. Glazner, D.E. Brenneman   +10 more
openaire   +1 more source

Activity-dependent neuroprotective protein (ADNP)-end-binding protein (EB) interactions regulate microtubule dynamics toward protection against tauopathy

Progress in Molecular Biology and Translational Science, 2021
Illana Gozes, Yanina Ivashko-Pachima
exaly  

AL-108 and AL-208, formulations of the neuroprotective NAP fragment of activity-dependent neuroprotective protein, for cognitive disorders.

Current opinion in investigational drugs (London, England : 2000), 2008
Allon Therapeutics Inc is developing AL-108, an intranasally administered, eight-amino-acid peptide fragment (known as NAP) of activity-dependent neuroprotective protein, and AL-208, an intravenous formulation of NAP. AL-108 is undergoing phase II trials for cognitive impairment in Alzheimer's disease and schizophrenia.
openaire   +1 more source

Activity-Dependent Neuroprotective Protein (ADNP) and Davunetide (NAP)

2013
I. Gozes, P.W. Baas
openaire   +1 more source

Revealing the role of activity dependent neuroprotective protein during embryogenesis

Neuropeptides, 2006
S. Mandel, I. Gozes
openaire   +1 more source